CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-24 | Jones David Scott SVP & Chief Commercial Officer | Option exercise 10b5-1 | +5,700 | $3.26 | $19K | 49,262 |
| 2024-01-24 | Jones David Scott SVP & Chief Commercial Officer | Sale 10b5-1 | −5,700 | $25.01 | $143K | 43,562 |
| 2024-01-24 | Jones David Scott SVP & Chief Commercial Officer | Sale 10b5-1 | −5,600 | $25.01 | $140K | 37,962 |
| 2024-01-24 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,600 | 18,625 | ||
| 2024-01-24 | Jones David Scott SVP & Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,700 | 85,455 | ||
| 2024-01-24 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +5,651 | $12.90 | $73K | 42,156 |
| 2024-01-24 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +5,600 | $13.13 | $74K | 47,756 |
| 2024-01-24 | Paggiarino Dario A. Chief Medical Officer | Sale | −5,600 | $25.01 | $140K | 42,156 |
| 2024-01-24 | Paggiarino Dario A. Chief Medical Officer | Sale | −5,651 | $25.02 | $141K | 36,505 |
| 2024-01-24 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,600 | 51,604 | ||
| 2024-01-24 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −5,651 | 16,935 | ||
| 2024-01-24 | Lurker Nancy Executive Vice Chair | Sale 10b5-1 | −29,956 | $24.98 | $748K | 135,441 |
| 2024-01-24 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) 10b5-1 | −112,700 | 338,100 | ||
| 2024-01-24 | Lurker Nancy Executive Vice Chair | Gift · Stock Option (Right to Buy) 10b5-1 | +112,700 | 112,700 | ||
| 2024-01-23 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +3,096 | $13.13 | $41K | 39,601 |
| 2024-01-23 | Paggiarino Dario A. Chief Medical Officer | Option exercise | +2,039 | $12.90 | $26K | 41,640 |
| 2024-01-23 | Paggiarino Dario A. Chief Medical Officer | Sale | −2,039 | $25.00 | $51K | 39,601 |
| 2024-01-23 | Paggiarino Dario A. Chief Medical Officer | Sale | −3,096 | $25.00 | $77K | 36,505 |
| 2024-01-23 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −3,096 | 57,204 | ||
| 2024-01-23 | Paggiarino Dario A. Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −2,039 | 22,586 |
Page 15 of 18 · 352 trades